|
ANLN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.72980543619883E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.05749999657468E-08 |
| Normal-vs-Stage2 |
1.717390E-03 |
| Normal-vs-Stage3 |
1.92569999946102E-07 |
| Normal-vs-Stage4 |
5.58920000000018E-05 |
| Stage1-vs-Stage2 |
7.049400E-01 |
| Stage1-vs-Stage3 |
1.670250E-02 |
| Stage1-vs-Stage4 |
3.624100E-03 |
| Stage2-vs-Stage3 |
1.619350E-01 |
| Stage2-vs-Stage4 |
9.520500E-03 |
| Stage3-vs-Stage4 |
5.379700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.66769947746093E-11 |
| Normal-vs-AfricanAmerican |
6.959100E-03 |
| Normal-vs-Asian |
1.897040E-01 |
| Caucasian-vs-AfricanAmerican |
2.115800E-03 |
| Caucasian-vs-Asian |
4.971600E-01 |
| AfricanAmerican-vs-Asian |
3.049000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.11940029362745E-10 |
| Normal-vs-Female |
3.27399999999756E-07 |
| Male-vs-Female |
3.871800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.847930E-02 |
| Normal-vs-Age(41-60Yrs) |
1.49490000000974E-06 |
| Normal-vs-Age(61-80Yrs) |
6.73500033521179E-10 |
| Normal-vs-Age(81-100Yrs) |
4.314000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.509600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.224800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.753800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.364800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.247600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.786600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.291700E-02 |
| Normal-vs-Grade 2 |
1.48789999987464E-07 |
| Normal-vs-Grade 3 |
4.69640004663319E-09 |
| Normal-vs-Grade 4 |
4.37960000000404E-05 |
| Grade 1-vs-Grade 2 |
8.998400E-04 |
| Grade 1-vs-Grade 3 |
2.05149999999987E-05 |
| Grade 1-vs-Grade 4 |
2.358400E-04 |
| Grade 2-vs-Grade 3 |
7.264200E-02 |
| Grade 2-vs-Grade 4 |
2.379700E-03 |
| Grade 3-vs-Grade 4 |
7.579300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.61970000000156E-05 |
| Normal-vs-ccB subtype |
8.10620459645861E-11 |
| ccA subtype-vs-ccB subtype |
2.63739999994961E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.30730000047485E-07 |
| Normal-vs-N1 |
4.999700E-03 |
| N0-vs-N1 |
3.119900E-02 |
|
|
